GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avivagen Inc (OTCPK:VIVXF) » Definitions » ROA %

Avivagen (Avivagen) ROA % : -1,260.71% (As of Jul. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Avivagen ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Avivagen's annualized Net Income for the quarter that ended in Jul. 2023 was $-2.82 Mil. Avivagen's average Total Assets over the quarter that ended in Jul. 2023 was $0.22 Mil. Therefore, Avivagen's annualized ROA % for the quarter that ended in Jul. 2023 was -1,260.71%.

The historical rank and industry rank for Avivagen's ROA % or its related term are showing as below:

VIVXF' s ROA % Range Over the Past 10 Years
Min: -553.57   Med: -210.11   Max: -93.19
Current: -553.57

During the past 13 years, Avivagen's highest ROA % was -93.19%. The lowest was -553.57%. And the median was -210.11%.

VIVXF's ROA % is ranked worse than
99.35% of 1083 companies
in the Drug Manufacturers industry
Industry Median: 1.54 vs VIVXF: -553.57

Avivagen ROA % Historical Data

The historical data trend for Avivagen's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avivagen ROA % Chart

Avivagen Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -192.69 -191.89 -233.60 -231.47 -233.58

Avivagen Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -320.44 -335.44 -484.51 -1,112.05 -1,260.71

Competitive Comparison of Avivagen's ROA %

For the Drug Manufacturers - Specialty & Generic subindustry, Avivagen's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avivagen's ROA % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avivagen's ROA % distribution charts can be found below:

* The bar in red indicates where Avivagen's ROA % falls into.



Avivagen ROA % Calculation

Avivagen's annualized ROA % for the fiscal year that ended in Oct. 2022 is calculated as:

ROA %=Net Income (A: Oct. 2022 )/( (Total Assets (A: Oct. 2021 )+Total Assets (A: Oct. 2022 ))/ count )
=-4.431/( (2.797+0.997)/ 2 )
=-4.431/1.897
=-233.58 %

Avivagen's annualized ROA % for the quarter that ended in Jul. 2023 is calculated as:

ROA %=Net Income (Q: Jul. 2023 )/( (Total Assets (Q: Apr. 2023 )+Total Assets (Q: Jul. 2023 ))/ count )
=-2.824/( (0.241+0.207)/ 2 )
=-2.824/0.224
=-1,260.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Jul. 2023) net income data. ROA % is displayed in the 30-year financial page.


Avivagen  (OTCPK:VIVXF) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jul. 2023 )
=Net Income/Total Assets
=-2.824/0.224
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-2.824 / 0.124)*(0.124 / 0.224)
=Net Margin %*Asset Turnover
=-2277.42 %*0.5536
=-1,260.71 %

Note: The Net Income data used here is four times the quarterly (Jul. 2023) net income data. The Revenue data used here is four times the quarterly (Jul. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Avivagen ROA % Related Terms

Thank you for viewing the detailed overview of Avivagen's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Avivagen (Avivagen) Business Description

Traded in Other Exchanges
Address
100 Sussex Drive, Ottawa, ON, CAN, K1A 0R6
Avivagen Inc is a Canadian-based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's health defenses. The company's products are based on OxC-beta Technology. Its geographical segments include the Philippines, which is the key revenue driver; Mexico; Thailand; United States; Malaysia; Taiwan; Brazil; and others.

Avivagen (Avivagen) Headlines

From GuruFocus

Avivagen Announces Distribution in China for Vivamune

By Marketwired Marketwired 06-01-2018

Avivagen Retains ITG to Conduct Market Making Activities

By Marketwired Marketwired 10-02-2018

Avivagen Announces CEO Letter to Shareholders

By Marketwired Marketwired 01-17-2019

Avivagen Announces Agreement to Terminate China JV

By Marketwired Marketwired 08-07-2018

Avivagen to Exhibit Vivamune at SuperZoo

By Marketwired Marketwired 06-22-2018

Avivagen Inc. Announces Change of Auditor

By Marketwired Marketwired 01-04-2019